메뉴 건너뛰기
American Journal of Kidney Diseases
Volumn 60, Issue 1, 2012, Pages 169-170
Discounting the efficacy of sulodexide in diabetic nephropathy is premature
Author keywords

[No Author keywords available]
Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN FRACTION; SULODEXIDE; SULONEX; UNCLASSIFIED DRUG; VESSEL 2F;
EID: 84862632961     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.01.029     Document Type: Letter
Times cited : (11)
References (5)
  • 1
    • 80054968148 scopus 로고    scopus 로고
    • Sulodexide for diabetic nephropathy: Another one bites the dust
    • House AA, Weir MA. Sulodexide for diabetic nephropathy: another one bites the dust. Am J Kidney Dis. 2011;58:692-694.
    • (2011) Am J Kidney Dis , vol.58 , pp. 692-694
    • House, A.A.1    Weir, M.A.2
  • 2
    • 80055018022 scopus 로고    scopus 로고
    • Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: A randomized controlled trial
    • Lewis EJ, Lewis JB, Greene T, et al. Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis. 2011;58:729-736.
    • (2011) Am J Kidney Dis , vol.58 , pp. 729-736
    • Lewis, E.J.1    Lewis, J.B.2    Greene, T.3
  • 3
    • 0036014944 scopus 로고    scopus 로고
    • Oral sulodexide reduces albuminuria in microalbuminuria and macroalbuminuric type 1 and type 2 diabetic patients: The DiNAS randomized trial
    • Gambaro G, Kinalska I, Oksa A, et al. Oral sulodexide reduces albuminuria in microalbuminuria and macroalbuminuric type 1 and type 2 diabetic patients: the DiNAS randomized trial. J Am Soc Nephrol. 2002;13:1615-1625.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 1615-1625
    • Gambaro, G.1    Kinalska, I.2    Oksa, A.3
  • 4
    • 84863393468 scopus 로고    scopus 로고
    • Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy
    • Packham DK,Wolfe R, Reutens AT, et al. Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy. J Am Soc Nephrol. 2012;23:123-130.
    • (2012) J Am Soc Nephrol , vol.23 , pp. 123-130
    • Packham, D.K.1    Wolfe, R.2    Reutens, A.T.3
  • 5
    • 33746691250 scopus 로고    scopus 로고
    • The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy
    • Abaterusso C, Gambaro G. The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. Treat Endocrinol. 2006;5:211-222.
    • (2006) Treat Endocrinol , vol.5 , pp. 211-222
    • Abaterusso, C.1    Gambaro, G.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.